Type de formulation: Poudre
IUPAC Name: (3S,3'R,3'aS,6'S,6aS,6bS,7'aR,9R,11aS,11bR)-3',6',10,11b-tetramethylspiro[2,3,4,6,6a,6b,7,8,11,11a-decahydro-1H-benzo[a]fluorene-9,2'-3a,4,5,6,7,7a-hexahydro-3H-furo[3,2-b]pyridine]-3-ol
EC Number: 628-058-8
Molecular Weight: 411.6
Chemical Formula: C₂₇H₄₁NO₂
CAS Number: 4449-51-8
Pureté: Teneur ≥98%
Poids moléculaire: 414.41 g/mol
Application: Antagoniste de la voie Hedgehog (Hh) (réactif de recherche)
Statut réglementaire: Matériau de qualité pharmaceutique pour la fabrication de médicaments
Norme de certification: Conforme à la/aux norme(s) pharmacopée ChP, USP, BP, EP

Autres informations

Description supplémentaire:

Cyclopamine Powder (CAS 4354-76-1, C22H22O8 per this listing, molecular weight 414.41, 98% specification) is manufactured to pharmaceutical grade by Shaanxi Virgin Pharmaceutical Co., Ltd. under Chinese, US, British and European pharmacopoeia standards. It is described as a Hedgehog (Hh) pathway antagonist with an IC50 of 46 nM in the Hh cell assay, and it is sold into North America, Central/South America, Western Europe, Eastern Europe and Asia.